Clinical Trial Update: A Phase II Study of Maintenance With Azacitidine in MDS Patients [Phase 2]

View source ↗

Summary

Phase II study evaluating maintenance azacitidine in patients with myelodysplastic syndromes and acute myeloid leukemia; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: Leukemia, Myelocytic, Acute, Myelodysplastic Syndromes | Phase 2 | Status: TERMINATED